Search

Arena Pharmaceuticals (ARNA)

8.71
+0.16 (+1.87%)
Range8.55 - 8.73
52 week1.70 - 13.50
Open8.59
Vol/Avg.9,116,470
Mkt cap1.893B
P/E-
EPS-0.508
Book/share0.54
Short ratio4.70
PEG-
EPS est.0.16

ARNA analyst ratings

Loading ...
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
 

ARNA price and earnings targets

Loading ...
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.

ARNA earnings

Date
Actual
Expected
Prev Yr Qtr
11/6/2012
-0.07
-0.09
-0.16
8/9/2012
-0.12
-0.07
-0.16
3/14/2012
-0.16
-0.15
-0.23

Arena Pharmaceuticals (ARNA) Upgrades

Date
Analyst
Old Rating
New Rating
12/23/2010
Summer Street
Sell
Neutral Summer St
07/16/2010
J. P. Morgan
Neutral
Overweight
07/02/2010
Leerink Swann
Market Perform
Outperform
01/15/2008
BofA
Neutral
Buy
12/22/2006
A. G. Edwards
Buy
Hold

Arena Pharmaceuticals (ARNA) Downgrades

Date
Analyst
Old Rating
New Rating
09/17/2010
Davenport
Buy
Neutral $ 8
09/14/2010
Barclays
Equalweight
Underweight
09/09/2010
Hapoalim Securities
Hold
Sell PT $ 650
08/02/2010
JP Morgan
Overweight
Neutral
07/16/2010
Rodman & Renshaw
Market Perform
Market Underperform
09/15/2009
Rodman and Renshaw
Market Outperform
Market Perform

Arena Pharmaceuticals (ARNA) New Coverage

Date
Analyst
Rating
09/06/2012
Credit Suisse
Underperform
10/10/2007
Wachovia
Market Perform

Trading Offers